Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 50652
MIM: 604845
HGNC: 8637
Ensembl: ENSG00000225937
Variants:
dbSNP: 50652
ClinVar: 50652
TCGA: ENSG00000225937
COSMIC: PCA3
RNA/Proteins
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37583257 | 2023 | lncRNA PCA3 Suppressed Carotid Artery Stenosis and Vascular Smooth Muscle Cell Function via Negatively Modulating the miR-124-3p/ITGB1 Axis. | 0 |
| 37583257 | 2023 | lncRNA PCA3 Suppressed Carotid Artery Stenosis and Vascular Smooth Muscle Cell Function via Negatively Modulating the miR-124-3p/ITGB1 Axis. | 0 |
| 33758375 | 2022 | PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes. | 1 |
| 34656688 | 2022 | Circulating RNAs in prostate cancer patients. | 26 |
| 36246565 | 2022 | Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men. | 1 |
| 33758375 | 2022 | PCA3 controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes. | 1 |
| 34656688 | 2022 | Circulating RNAs in prostate cancer patients. | 26 |
| 36246565 | 2022 | Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men. | 1 |
| 34052307 | 2021 | LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling. | 8 |
| 34052307 | 2021 | LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling. | 8 |
| 32661204 | 2020 | Promoter polymorphisms of the PCA3 gene are not associated with its overexpression in prostate cancer patients. | 0 |
| 32661204 | 2020 | Promoter polymorphisms of the PCA3 gene are not associated with its overexpression in prostate cancer patients. | 0 |
| 30203935 | 2019 | Comparison of diagnostic efficacy by two urine PCA3 scores in prostate cancer patients undergoing repeat biopsies. | 3 |
| 30664734 | 2019 | Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS). | 16 |
| 31468286 | 2019 | Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas. | 10 |
Citation
Dessen P
PCA3 (prostate cancer associated 3)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/41653/pca3
